MGRM: Monogram Technologies Inc. Long-Term Debt Volume

Graphic logo of Monogram Orthopedics Inc. (MGRM)

Monogram Technologies (MGRM) has earned physician recognition by developing ultra-precise joint replacement systems that enhance surgical reliability. However, reliance on Asian microchips and trade barriers create risks of component shortages. The market perceives the company as a bold technological leader, fueling venture optimism. Long-term debt stands at 0.00, and the price action below illustrates the market performance of this robotics manufacturer.

MGRM Monogram Technologies: Company Long-Term Debts in the range 02/21/2024 - 10/18/2025

Analytical breakdowns for Monogram Technologies

- price and consensus price forecast:
Share Price monogramorthopedics.com|MGRM - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Monogram Orthopedics|MGRM - Enterprise Value
- book capitalization data:
Accounting Value per Share Monogram Orthopedics|MGRM - Book Capitalization|Market Capitalization to Book Value Ratio monogramorthopedics.com|MGRM - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Monogram Technologies|MGRM - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Monogram Orthopedics Inc.|MGRM - Company Aggregate Debts|Debts to Net Assets Monogram Orthopedics|MGRM - Company Long-Term Debt|Company Short-Term Indebtedness Monogram Orthopedics
General company analysis:monogramorthopedics.com (MGRM)
Mass-produced product of Monogram Orthopedics Inc.

For Monogram Technologies (MGRM), long-term liabilities determine the funding stability for developments in robotic orthopedics. By analyzing the company's long-term debt volume, an investor assesses the aggregate of loans with maturities exceeding one year. This metric measures the financial leverage required to scale the production of 3D implants. An increase in this indicator requires a comparison with operating profit to eliminate the issuer's insolvency risks.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Sharps Tech - Company Long-Term Liabilities|INFU: Company Long-Term Debts|UTMD (Utah Medical Products) - Company Long-Term Debt|KORU Medical (KRMD) - Company Long-Term Liabilities|Company Long-Term Debts NYXH (Nyxoah)|Long-Term Debt MBOT|Company Long-Term Debt Pro-Dex Corp PDEX|Company Long-Term Indebtedness Zentek Corp ZTEK|Company Long-Term Liabilities Elutia Inc. (ELUT)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP: Long-Term Debt Volume|HBIO (Harvard Bioscience, Inc.) - Company Long-Term Debt|FEMY (Femasys Corporation) - Company Long-Term Liabilities|Company Long-Term Debt MHUA (Meihua Medical Technologies)|Long-Term Debt POAI|Company Long-Term Debt Callan JMB Inc CJMB|Company Long-Term Indebtedness ATRI (Atrion Corp.)|NURO: Company Long-Term Debt